Advertisement

International Journal of Clinical Pharmacy

, Volume 39, Issue 4, pp 867–873 | Cite as

Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation

  • Wei Terk ChangEmail author
  • Stefan R. Kowalski
  • Wassana Sorich
  • Christopher P. Alderman
Research Article

Abstract

Background There is a relative paucity of information to characterise potential changes in medication regimen complexity and prevalence of prescribing of potentially inappropriate medications after hospitalisation, both in Australia and elsewhere. Objective To evaluate medication regimen complexity and the prevalence of potentially inappropriate medications before and after admission to hospital. Setting General medical units of a tertiary care hospital in Australia. Methods Retrospective cohort study of patients aged 65 years and above. Medication complexity was measured by using the Medication Regimen Complexity Index (MRCI). Main outcome measure The primary outcome was the change in the Medication Regimen Complexity Index for all prescribed medications after hospitalization. Results A convenience sample of 100 patients was included in the study. There was a significant change in the mean medication complexity score (as measured using the MRCI), increasing from 29 at the time of admission to 32 at the time of discharge (p < 0.05). Factors such as baseline medication regimen complexity (pre-admission MRCI) and length of stay in the hospitals appear to influence the change in medication complexity. However, the proportion of patients prescribed at least one potentially inappropriate medicine (PIM) decreased significantly, from 52% pre-hospitalization to 42% at discharge (p = 0.04). Conclusions Relative to the time of admission, overall medication complexity increased and the proportion of patients who were prescribed PIMs decreased after hospitalisation.

Keywords

Australia Beers criteria Medication regimen complexity index Potentially inappropriate medication 

Notes

Acknowledgements

The authors would like to acknowledge the help of Winifred Greenshields, Associate Director of Pharmacy, Southern Adelaide Local Health Network, who assisted by facilitating data collection. We also thank Professor Adrian Esterman, Professor of Biostatistics from the University of South Australia, for his valuable advice. We also acknowledge and appreciate support from the Ministry of Health of Singapore and Ng Teng Fong General Hospital for the first author’s participation in the study.

Funding

The authors confirm that no funding from third party has been received.

Conflicts of interest

There is no conflict of interest involved in the publication of the study findings.

References

  1. 1.
    Betteridge TM, Frampton CM, Jardine DL. Polypharmacy—we make it worse! A cross-sectional study from an acute admissions unit. Intern Med J. 2012;42:208–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Saad M, Harisingani R, Katinas L. Impact of geriatric consultation on the number of medications in hospitalized older patients. Consult Pharm. 2012;27:42–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Corsonello A, Pedone C, Corica F, Incalzi RA. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag. 2007;3:197–203.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Elliott RA, O’Callaghan CJ, Paul E, George J. Impact of an intervention to reduce medication regimen complexity for older hospital inpatients. Int J Clin Pharm. 2013;35:217–24.CrossRefPubMedGoogle Scholar
  5. 5.
    George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38:1369–76.CrossRefPubMedGoogle Scholar
  6. 6.
    Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G. Elderly patients’ problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996;49:255–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.CrossRefPubMedGoogle Scholar
  8. 8.
    Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994;16:110–7.PubMedGoogle Scholar
  9. 9.
    Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther. 1998;20:764–71.CrossRefPubMedGoogle Scholar
  10. 10.
    Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17:123–32.CrossRefPubMedGoogle Scholar
  11. 11.
    Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55:M554–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31:4–11.CrossRefPubMedGoogle Scholar
  13. 13.
    Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE study. J Gerontol A Biol Sci Med Sci. 2006;61:170–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Page RL II, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    American Geriatrics Society. Beers criteria update expert panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older. J Am Geriatr Soc. 2015;2015(63):2227–46.Google Scholar
  16. 16.
    Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med. 1995;155:1801.CrossRefPubMedGoogle Scholar
  17. 17.
    Elliott RA, O’Callaghan CJ. Impact of hospitalisation on the complexity of older patients’ medication regimens and potential for regimen simplification. J Pharm Pract Res. 2011;41:21–5.CrossRefGoogle Scholar
  18. 18.
    Stange D, Kriston L, Wolff von A, Baehr M, Dartsch DC. Simplification of medication regimens—a novel aspect of pharmaceutical care in hospital. Eur J Hosp Pharm. 2012;19:222.CrossRefGoogle Scholar
  19. 19.
    Wolfe MM. Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders. In: Post TW (Ed), UpToDate, Waltham, MA. Accessed 02 Jul 2016. https://www.uptodate.com/contents/overview-and-comparison-of-the-proton-pump-inhibitors-for-the-treatment-of-acid-related-disorders?source=search_result&search=over%20view%20proton%20pump%20inhibitors&selectedTitle=1~150.
  20. 20.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med. 2004;351:543–51.CrossRefPubMedGoogle Scholar
  21. 21.
    Australian Medicines Handbook 2016 (online). Adelaide: Australian medicines handbook Pty Ltd; 2016 January. http://amhonline.amh.net.au/.
  22. 22.
    Therapeutic Goods Administration. Database of adverse event notifications (DAEN). Canberra, Australia. http://apps.tga.gov.au/PROD/DAEN/daen-entry.aspx.

Copyright information

© Springer International Publishing 2017

Authors and Affiliations

  1. 1.Pharmacy DepartmentNg Teng Fong General HospitalSingaporeSingapore
  2. 2.School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia
  3. 3.Pharmacy DepartmentRepatriation General HospitalAdelaideAustralia
  4. 4.Ward Medication ManagementAbbotsford, MelbourneAustralia

Personalised recommendations